Literature DB >> 9768708

Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization.

T Sakuma1, Y Hayashi, K Sumii, M Imazu, M Yamakido.   

Abstract

OBJECTIVES: This study sought to determine whether microvascular integrity in the risk area (RA) for myocardial infarction (MI) one day after recanalization predicts the outcome in patients with first acute MI.
BACKGROUND: Immediately after recanalization, microcirculation in the RA is modified by both hyperemic response and microvascular impairment.
METHODS: Fifty consecutive patients who underwent serial myocardial contrast echocardiography before and one day after recanalization (day 2) were studied. All patients had a completely occluded lesion in the left anterior descending coronary artery alone, and underwent successful reperfusion therapy. The relative size of the initial RA (RA ratio) and peak gray scale ratio (PGSR) within the RA on day 2 were determined. Patients were followed for a median of 22 months to evaluate clinical outcome.
RESULTS: On day 2, PGSR was a median of 0.46. Study patients were subdivided into two groups, group A of 24 patients with acceptable opacification (PGSR > 0.46 on day 2) and group B of 26 patients without it. Major cardiac events (cardiac death, nonfatal MI and repeat admission for congestive heart failure) were more frequently observed in group B (28% vs. 4%, Cox hazard ratio=8.5, p=0.05, 95% confidence interval [CI] 1.03 to 69.9). The median value of the RA ratio was 0.45. Patients (n=15) with RA ratio > 0.45 on day 1 and PGSR on day 2 < or = 0.46 exhibited a 10.7-fold relative risk for major cardiac events (p=0.005, 95% CI 2.06 to 55.8) and a 3.69-fold relative risk for composite cardiac events (major cardiac events and target lesion revascularizations) after the initial intervention (p=0.004, 95% CI 1.51 to 9.04).
CONCLUSIONS: The assessment of both the size of the initial RA and microvascular integrity on day 2 enables precise determination of the efficacy of reperfusion therapy and prediction of the short- and intermediate-term prognoses of patients with recanalized MI.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768708     DOI: 10.1016/s0735-1097(98)00342-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  22 in total

Review 1.  Added value of contrast echocardiography in assessing myocardial viability.

Authors:  A Nagy; F L Dini; D Rovai
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 2.  Clinical and economic outcomes assessment with myocardial contrast echocardiography.

Authors:  L J Shaw; M J Monaghan; P Nihoyannopolous
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 3.  The "no-reflow" phenomenon: basic science and clinical correlates.

Authors:  Thorsten Reffelmann; Robert A Kloner
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

Review 4.  ST-segment monitoring in patients with acute coronary syndromes.

Authors:  Per Johanson; Galen S Wagner; Mikael Dellborg; Mitchell W Krucoff
Journal:  Curr Cardiol Rep       Date:  2003-07       Impact factor: 2.931

5.  Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model.

Authors:  Stavros Stavrakis; John Terrovitis; Elias Tsolakis; Stavros Drakos; Argirios Dalianis; Michael Bonios; Dimitrios Koudoumas; Konstantinos Malliaras; John Nanas
Journal:  J Cardiovasc Transl Res       Date:  2010-12-09       Impact factor: 4.132

6.  Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Murat Sezer; Irem Okcular; Taner Goren; Huseyin Oflaz; Yilmaz Nisanci; Berrin Umman; Fehmi Mercanoglu; Ahmet K Bilge; Mehmet Meric; Sabahattin Umman
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

Review 7.  Cardiovascular therapeutic uses of targeted ultrasound contrast agents.

Authors:  Susan T Laing; David D McPherson
Journal:  Cardiovasc Res       Date:  2009-07-06       Impact factor: 10.787

Review 8.  Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.

Authors:  Jennifer M Singelyn; Karen L Christman
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

Review 9.  Pharmacologic reperfusion therapy for acute myocardial infarction.

Authors:  Harry C Lowe; Briain D Mac Neill; Frans Van de Werf; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

10.  Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction.

Authors:  C Michael Gibson; James A de Lemos; Sabina A Murphy; Susan J Marble; Kent W Dauterman; Andrew Michaels; Hal V Barron; Elliott M Antman
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.